Discover My LEO Pharma

My LEO Pharma is designed to support you throughout your treatment journey.

This site is designed to provide information to patients who have been prescribed a LEO Pharma medicine. If you are a member of the public and have not been prescribed any of these LEO Pharma medicines here is a link to the LEO Pharma UK/IE website. Should you have any concerns or questions regarding your treatment, please speak to your doctor or nurse.

Please select one of the options below.

Group 31

 

I am, or care for, a resident of the UK or Republic of Ireland who has been prescribed Adtralza®▼ (tralokinumab).

Confirm

 

I am, or care for, a resident of the UK or Republic of Ireland who has been prescribed Enstilar® (calcipotriol/betamethasone dipropionate).

Confirm

Reporting side effects

Adtralza®▼ (tralokinumab) is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

For the United Kingdom

You can also report side effects via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App Store.

For the Republic of Ireland

The Health Products Regulatory Authority (HPRA) monitors the safety and quality of all medicines available in Ireland. Should you wish, you can also report any suspected side effects directly via HPRA Pharmacovigilance,
Earlsfort Terrace, IRL- Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; Email: medsafety@hpra.ie.

By reporting side effects you can help provide more information on the safety of this medicine.

Date of preparation: October 2024
UK/IE MAT-74846